Karin Wehlin
Chief Executive Officer at DIAGONAL BIO AB
Karin Wehlin active positions
| Companies | Position | Start | End |
|---|---|---|---|
| DIAGONAL BIO AB | Director/Board Member | 31/12/2022 | - |
| Chief Executive Officer | 22/11/2023 | - |
Career history of Karin Wehlin
Former positions of Karin Wehlin
| Companies | Position | Start | End |
|---|---|---|---|
| BOMILL AB | Chief Executive Officer | - | - |
Respiratorius AB
 Respiratorius AB Pharmaceuticals: MajorHealth Technology Respiratorius AB engages in the development of drug candidates for Chronic Obstructive Pulmonary Disease, asthma, and cancer. The company was founded by Lars Christer Fedrik Fåhraeus and Staffan Skogwall in 1999 and is headquartered in Lund, Sweden. | Chief Executive Officer | - | - |
| LU Food Science AB | Chief Executive Officer | - | - |
| EQL PHARMA AB | Founder | 31/12/2005 | - |
Training of Karin Wehlin
| University of Lund | Masters Business Admin |
Statistics
International
| Sweden | 7 |
Operational
| Chief Executive Officer | 4 |
| Founder | 1 |
| Director/Board Member | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 2 |
| Technology Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 4 |
|---|---|
| EQL PHARMA AB | Health Technology |
 | Health Technology |
| BOMILL AB | Technology Services |
| DIAGONAL BIO AB | Health Technology |
| Private companies | 1 |
|---|---|
| LU Food Science AB |
- Stock Market
- Insiders
- Karin Wehlin
- Experience
